Loading…
← CockpitCompetitor Analysis › NH.NS Narayana HrudayalayaOpen in the cockpit ↗

Narayana HrudayalayaNH.NSCompetitor analysis, valuation and peers

India · INR·Pharma & Healthcare›Hospital/Nursing Management

Multi-specialty hospital chain founded by Dr. Devi Shetty, known for high-volume, lower-cost cardiac and specialty care.

≈ India's high-volume, low-cost cardiac-care hospital modelMomentum strong 66
Mkt cap
$4.13B
US dollars, full cap
Free float
34%
of shares outstanding
$/day
$3.24M
20-day average traded
Fwd P/E
34.2×
forward earnings
ROIC−WACC
-0.4 pp
WACC 12.4%
Hurdle
+6 pp
Req g minus delivered
Next earnings
86 days
12 Feb 2027
Close · INR₹1,891
1D-0.8%
1W+1.3%
1M+8.6%
3M+4.9%
6M+0.4%
YTD0.0%
1Y+7.5%
ATR %2.6%
Beta0.74
52w lowhigh9.7% off high

What Narayana Hrudayalaya does

Multi-specialty hospital chain founded by Dr. Devi Shetty, known for high-volume, lower-cost cardiac and specialty care.

Charges patients per procedure, with insurers, government health schemes and self-paying patients all in the mix, and profit rests on filling beds and operating theatres at high volume and low unit cost. The Bengaluru campus is the flagship; a Cayman Islands hospital serves patients from the Caribbean and North America.

In one line: India's high-volume, low-cost cardiac-care hospital model.

Products and services

  • Cardiac sciences
  • Oncology, neurosciences
  • Multi-specialty care (India + Cayman Islands)

Customers

  • Domestic patients
  • International/medical tourism patients

Where it sits in the supply chain

  • Healthcare services
  • Hospital/tertiary care
  • Multi-specialty hospital chain

What could go right

  • Rising healthcare demand in India
  • International hospital scale-up

What could go wrong

  • Capex-heavy bed expansion
  • Insurance reimbursement pressure

Moat: narrow (scale, brand, process know-how). High-volume, standardized-cost surgical model built to serve price-sensitive patients at scale.

Headquarters: Bengaluru, India · Founded: 2000 · Employees: 15,467

Named competitors

Narayana Hrudayalaya at a glance

Size Narayana Hrudayalaya (NH.NS) is an India Health Care company (Hospital/Nursing Management) with a market value of $4.13B, the 235th largest of 1,066 India companies the cockpit tracks. Shares closed at ₹1,891 on 18 Nov 2026.

Performance Over six months the shares gained 0.4%, against +1.1% for the median peer and +3.8% for the India market (cap-weighted) — 10th lowest of 20 in its peer set.

Growth Revenue grew 71.4% over the last twelve months (peer median +9.5%); the operating margin is 12.7% (peer median 10.9%).

Valuation It trades at 34.2× forward earnings against a peer median of 44.7× (9th cheapest of 19).

Price implies For today's price to make sense, revenue must grow about 31% a year for seven years (Req g). Recent delivered growth is +25%, so the hurdle is +6 pp: the price needs faster growth than the company has been delivering — of companies that just grew 25–50% a year, 93.8% slowed down over the next four years.

Capital Return on invested capital runs 0.4 points below its cost of capital (12.4% WACC).

Next results Next results expected around 12 Feb 2027 (exchange calendar; dates can move).

Relative performance

9010011021 May 202621 Aug 202618 Nov 2026Peer median 100NH.NS 99
Six months, rebased to 100: Narayana Hrudayalaya against the median of its 20 peers (local-currency closes).

Narayana Hrudayalaya financials

Reported figures in INR; fiscal year ends 2026-03-31. TTM = trailing twelve months.
TTMFY2025FY2024FY2023FY2022
Revenue₹103B₹79.0B₹54.8B₹48.9B₹45.2B
Revenue growth—+44%+12%+8%—
Gross profit₹37.9B₹21.8B₹14.2B₹12.3B₹11.0B
EBITDA₹19.0B₹16.7B₹13.1B₹11.7B₹9.89B
Net income₹8.59B₹8.06B₹7.90B₹7.89B₹6.06B
Free cash flown/a₹5.98B-₹1.96B₹412M₹5.27B
Capital expendituren/a₹8.75B₹10.8B₹9.71B₹5.22B
Total debt₹60.8B₹58.6B₹24.3B₹16.3B₹8.84B

Quarterly statements and history in the cockpit →

Narayana Hrudayalaya competitor charts

The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.

Performance: 6-month against 1-month return

0%+50%+100%0%+50%MEDANTASGRYKIMSNHCFORTISASTERDMCHEPACSBKDRHCARDTEXE301267MAXHEALTHUHS000516AEVSNH.NS6-month return →1-month return →
Up and to the right = strong over both horizons. Narayana Hrudayalaya is the large dot.

Fundamentals: revenue growth against valuation

0%+20%+40%+60%0×200×400×MEDANTASGRYKIMSFORTISASTERDMCHE600763BKDEXEMANIPALHOSMAXHEALTHAEVSNH.NSRevenue growth (TTM) →Forward P/E →
Further right = faster growth; higher = more expensive. The dashed lines are the peer medians. Narayana Hrudayalaya is the large dot.

Capital: growth delivered against growth the price implies

0%+20%+40%0%20%40%SGRYNHCFORTISASTERDMCHE600763PACSBKDRHCARDT301267MANIPALHOSMAXHEALTHUHSSIA000516AEVSNH.NSGrowth delivered (Del g) →Growth the price implies (Req g, 7 yrs) →
Above the diagonal = the price needs more growth than the company has been delivering; below = the price already allows for a slowdown. Narayana Hrudayalaya is the large dot.

Narayana Hrudayalaya competitors and peer comparison

Head to head with its named competitors (NH.NS vs APOLLOHOSP.NS vs MAXHEALTH.NS vs MEDANTA.NS)
CompanyMarket cap6M returnRevenue growthOp. marginForward P/EReq g
Narayana Hrudayalaya NH.NS$4.13B0%+71%13%34.2×31.2%
Apollo Hospitals Enterprise APOLLOHOSP.NS$13.6B+10%+19%12%51.0×33.3%
Max Healthcare Institute MAXHEALTH.NS$10.6B-4%+15%21%55.2×45.3%
Global Health MEDANTA.NS$4.13B+16%+26%17%50.4×n/a
Krishna Institute of Medical Sciences KIMS.NS$3.41B+2%+35%11%81.9×n/a

How Narayana Hrudayalaya compares with its peers

Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.

Narayana Hrudayalaya against its 20 peers (data as of 18 Nov 2026)
MeasureNH.NSPeer medianRank in peer set
1-month return+8.6%+5.4%8th highest of 21
6-month return+0.4%+1.1%10th lowest of 20
Distance from 52-week high-9.7%-16.7%5th highest of 21
Revenue growth (TTM)+71.4%+9.5%highest of 21
Operating margin12.7%10.9%10th highest of 21
Forward P/E34.2×44.7×9th cheapest of 19
Growth the price implies (Req g, 7 yrs)31.2%13.3%5th most demanding of 19
Growth delivered (Del g)+25.0%+9.2%4th highest of 19
Hurdle (Req g minus delivered)+6.2 pp+3.8 pp7th most demanding of 19
ROIC minus cost of capital-0.4 pp-2.5 pp9th highest of 21
EV / EBITDA21.9×18.3×7th most expensive of 16
Net debt / EBITDA1.6×3.0×6th least indebted of 18

Peer table

Peer set: Industry: the same industry and sector in any market, nearest in size
CompanyMarketMarket cap6M returnRevenue growthOp. marginForward P/EReq gDelivered g
Narayana Hrudayalaya NH.NSIndia$4.13B0%+71%13%34.2×31.2%+25.0%
Global Health MEDANTA.NSIndia$4.13B+16%+26%17%50.4×n/an/a
Surgery Partners SGRYUnited States$3.53B+100%+2%13%77.2×15.6%+12.2%
Krishna Institute of Medical Sciences KIMS.NSIndia$3.41B+2%+35%11%81.9×n/an/a
National HealthCare NHCUnited States$3.16B+1%+6%0%n/a6.4%+9.7%
Fortis Healthcare FORTIS.NSIndia$6.40B-17%+18%17%48.5×42.5%+17.9%
Aster DM Quality Care ASTERDM.NSIndia$6.83B-2%+50%16%63.5×48.6%-11.6%
Chemed CHEUnited States$7.12B+24%+5%14%20.2×3.3%+4.0%
Topchoice Medical 600763.SSChina$2.33B-12%+7%26%24.8×12.4%+6.9%
PACS PACSUnited States$7.35B+25%+11%8%17.5×7.5%+29.7%
Brookdale Senior Living BKDUnited States$2.06B-36%-8%6%482.6×19.3%-1.4%
Ramsay Health Care RHC.AXAustralia$8.31B+41%+4%5%31.4×14.0%+8.3%
Ardent Health ARDTUnited States$2.03B+52%+2%5%11.9×-1.7%+8.7%
Extendicare EXE.TOCanada$1.91B-16%+36%9%19.3×10.8%+8.5%
Huaxia Eye Hospital 301267.SZChina$1.78B-18%+2%15%23.5×2.1%+10.4%
Manipal Health Enterprises MANIPALHOS.NSIndia$9.69Bn/a+25%19%66.5×32.9%+28.8%
Max Healthcare Institute MAXHEALTH.NSIndia$10.6B-4%+15%21%55.2×45.3%+27.2%
Universal Health Services UHSUnited States$10.7B+13%+8%11%8.3×-1.8%+8.5%
Sienna Senior Living SIA.TOCanada$1.58B-8%+15%10%40.9×18.9%+8.6%
Xi'an International Medical Investment 000516.SZChina$1.46B-2%-1%-2%n/a12.7%+20.6%
Aevis Victoria AEVS.SWSwitzerland$1.43B+8%+15%-6%106.8×26.5%+10.2%

Questions

Who are Narayana Hrudayalaya's main competitors?
Named competitors: Apollo Hospitals (APOLLOHOSP.NS), Max Healthcare (MAXHEALTH.NS), Global Health (Medanta) (MEDANTA.NS), KIMS (KIMS.NS). The cockpit's measured peer set (industry) also includes Global Health (MEDANTA.NS), Surgery Partners (SGRY), Krishna Institute of Medical Sciences (KIMS.NS), National HealthCare (NHC), Fortis Healthcare (FORTIS.NS), Aster DM Quality Care (ASTERDM.NS).
Is Narayana Hrudayalaya expensive compared with its peers?
On forward p/e it trades at 34.2× against a peer median of 44.7×, 9th cheapest of 19 in its peer set. For today's price to make sense, revenue must grow about 31% a year for seven years (Req g). Recent delivered growth is +25%, so the hurdle is +6 pp: the price needs faster growth than the company has been delivering — of companies that just grew 25–50% a year, 93.8% slowed down over the next four years.
How has Narayana Hrudayalaya stock performed?
Over six months to 18 Nov 2026 the shares returned +0.4% against +1.1% for the median peer; over one year +7.5%.

How these numbers are made. Returns are close-to-close in local currency. Revenue growth and margins are trailing twelve months. Req g is the revenue growth that today's enterprise value requires for seven years at the company's own cost of capital; Delivered g is what it actually grew; the gap is the hurdle (honest precision about ±8 points, so read the ranking more than the decimal). No fair values, price targets or analyst ratings are shown, by design. Method and validation.